University of Ioannina
Προκαρκινικές βλάβες και νεοπλάσματα του δέρματος σε ασθενείς με μεταμόσχευση νεφρού: επίπτωση, επιπολασμός και αντιμετώπιση
Abstract
dc:descriptionIntroduction: The population of transplant patients in Greece, as well as in many countries of the Western world, has increased significantly in the last decade due to more transplantations performed and the use of highly effective immunosuppressive treatment protocols that increase life expectancy of these patients. However, due to the lifelong requirement for immunosuppression, these patients are at increased risk for a variety of cancers, among which the incidence of skin cancer is the highest. Skin cancers account for 40-50% of all post-transplant malignancies. Among them, keratinocyte skin cancers (squamous cell carcinoma [SCC], basal cell carcinoma [BCC], Bowen’s disease [BD]) account for 90-95% of all skin cancers and cause significant morbidity and mortality, as they tend to be more aggressive in transplant recipients than in the general population. Accurate assessment of their incidence, as well as identification of high-risk patients, plays an important role in designing and developing improved prevention strategies and in optimizing post-transplant monitoring. Furthermore, as renal transplant recipients often develop multiple keratinocyte skin carcinomas (KSC), the use of minimally invasive methods to treat these lesions is preferable to more destructive ones, such as surgery. Immunocryosurgery (combination of cryosurgery during immunostimulatory therapy with topical imiquimod) has shown efficacy >95% in the treatment of BCC and BD in immunocompetent patients. Aim of the study: The aim of the present observational study was dual: (a) To estimate the prevalence and incidence of precancerous lesions and skin neoplasms as well as their risk factors in a stable population of kidney transplant recipients from a specific geographical area (northwestern Greece and southern Albania). (b) To evaluate the safety, feasibility and efficacy of immunocryosurgery in the treatment of BCC and Bowen disease in renal transplant recipients. Patients and methods: This study is a cross-sectional and prospective study that included N=84 kidney transplant recipients who are being monitored for their transplant at the University Hospital of Ioannina. Patients were admitted to the study during 2015 and the study was completed in mid-2017. All patients were examined at least once a year and therefore at least twice each. At each visit, data were recorded based on a specific questionnaire, a complete dermatological examination was performed and clinical photographs were taken. The diagnosis of precancerous lesions (actinic cheilitis, actinic keratosis [AK]) was based on clinical and dermatoscopic criteria. In any lesion suspicious for malignancy, in lesions with uncertain clinical diagnosis or with atypical features, a biopsy was performed. Only histopathologically confirmed keratinocyte neoplasms were included in the study. All patients with precancerous lesions and cancers were treated and followed-up at 6 and 3 months respectively. Actinic keratoses were treated with either cryosurgery or imiquimod and all SCCs that were identified during standard biopsy evaluation of suspected lesions were referred for surgical treatment. All BCCs and all cases of Bowen disease were scheduled to be treated with immunocryosurgery (5 weeks of daily imiquimod application and one cryosurgery session on day 14). To evaluate the effect of immunocryosurgery on implant function and the safety of the method, key laboratory parameters (serum creatinine, urine protein and estimated glomerular filtration rate [eGFR]) were compared between patients subjected to immunocryosurgery and age-, sex- and immunosuppressive therapy-matched RTR not subjected to immunocryosurgery (controls). Results: The prevalence of patients with actinic keratosis during the first examination was 21.4% and the annual incidence of patients with actinic keratosis 17.9%. In total, up to the second examination, 25% of patients (21/84) developed actinic keratosis. The prevalence of patients with actinic cheilitis during the first examination was 32% (27/84). The annual incidence of patients with actinic cheilitis was 1.19% and overall by the second examination 33% of patients had developed actinic cheilitis. The prevalence of patients with KSC was 19% (16/84) for the period from the transplant to the first examination. 23.8% (20/84) of the patients developed KSC during the period from the transplantation to the second examination. All patients were examined prospectively and the annual incidence of patients with KSC (percentage of the population developing KSC per year) was found to be 11.9% (10/84 patients). The cumulative incidence of patients with KSC increased with the age of patients: at the age of 45 it was found 6.3%, at the age of 65 45.5% and at the age of 75 86.6%. In addition, the cumulative incidence of patients with KSC increased with the duration of immunosuppression: from 12.3% at 5 years, to 22.3% at 10 years and 54.8% at 25 years after transplantation. The annual incidence of KSC (number of tumors per person per year) was 0.17 (15 KSC / 84 patients). Twenty of the 84 patients (23.8%) developed a total of 45 keratinocyte neoplasms during the period from the transplantation to the second examination. The accrual of KSC (the ratio of neoplasms per patient) for the period from transplantation to the second examination was 45 KSC / 84 = 0.54. Of the 45 tumors, 19 (42%) were SCC, 18 (40%) were BCC and 8 (18%) were Bowen's disease. The BCC: SCC ratio was 0.94: 1. Among the patients who developed KSC, 11 had one, 4 had two, 2 had three, one patient had four, another had five, and another had eleven keratinocyte skin carcinomas. This distribution was checked with the one-Sample Kolmogorov test and it was found that there is a statistically significant deviation from random distribution (p = 0.011). Univariate analysis revealed statistically significant risk factors for the occurrence of KSC older age of patients (p = 0.000) and older age at transplantation (p = 0.023), consumption of more cigarettes per day (p = 0.010), neck elastosis (p = 0.048), presence of warts (p = 0.029) and number of AK (p = 0.048). The importance of ‘older’ age (p = 0.039), and the presence of AK (p = 0.000) was confirmed in the initial model of multivariate analysis. In the revised model without the inclusion of the factor AK, the statistically significant risk factors that emerged for the occurrence of KSC were, in addition to age, the ‘presence of warts’ (p = 0.032) and the history of azathioprine intake (p = 0.018). Ten BCC (8 nodular, 1 basosquamous, 1 superficial) and nine Bowen disease lesions in nine patients (7 men, 2 women; age range: 54-70 years, mean: 62.1 years) were treated with immunocryosurgery and followed-up for two to five years. BCCs diameter ranged from 6 to 14mm (mean 9.2mm). Five BCC were located on the ‘H area’ of the face. Seven out of ten BCC lesions cleared completely after one 5-week immunocryosurgery cycle, two cleared after repeat and intensified treatment cycles and one responded only partially (clearance rate: 90%). Seven out of nine BD lesions cleared after one 5-week immunocryosurgery cycle and one lesion after two cycles (clearance rate: 88.9%). No patient showed clinical or laboratory signs of transplant dysfunction during treatment or follow-up. Neither a significant deviation of the basic laboratory parameters of renal function after immunocryosurgery from their initial levels before treatment for patients with keratinocyte neoplasms was found, nor a statistically significant difference of the same parameters compared to the controls. Conclusions: This prospective study provides representative data on the increase in skin carcinogenesis in transplant patients in Greece. The high incidence of KSC identified in this study supports the urgent need to establish a clinical dermatology service for all transplant recipients. Early identification of those patients at higher risk of developing keratinocyte neoplasms according to their clinical profile and risk factors can help develop targeted prevention and early diagnosis strategies. Immunocryosurgery, a minimally invasive antineoplastic treatment modality, holds promise as a safe and feasible treatment alternative to surgery for BCC and Bowen disease in RTR.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsironi, Theodora
- Τσιρώνη, Θεοδώρα
Subjects
dc:subject × 20- Νεοπλάσματα δέρματος
- Μεταμόσχευση νεφρού
- Επίπτωση
- Επιπολασμός
- Προκαρκινικές βλάβες
- Αντιμετώπιση
- Neoplasms of skin
- Skin precancerous lesions
- Prevalence
- Incidence
- Renal transplant recipients
- Treatment
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Δερματολογία
- Ογκολογία
- Clinical Medicine
- Medical and Health Sciences
- Dermatology
- Oncology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52543